Publication

Byline

Location

US Patent Issued to Nivagen Pharmaceuticals on June 30 for "Lyophilized compositions of phenobarbital sodium salt" (California, Colorado Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,545, issued on June 30, was assigned to Nivagen Pharmaceuticals Inc. (Sacramento, Calif.). "Lyophilized compositions of phenobarbital sodiu... और पढ़ें


US Patent Issued to Agency for Science, Technology and Research on June 30 for "Methods for manipulating cell state transitions in cancer" (Singaporean Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,546, issued on June 30, was assigned to Agency for Science, Technology and Research (Singapore). "Methods for manipulating cell state trans... और पढ़ें


US Patent Issued to MESHABERASE, The United States of America as Represented by the Secretary Department of Health & Human Services on June 30 for "Use of cysteamine and derivatives thereof to suppress tumor metastases" (Maryland Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,547, issued on June 30, was assigned to MESHABERASE LLC (Potomac, Md.) and The United States of America as Represented by the Secretary Depa... और पढ़ें


US Patent Issued to Nacuity Pharmaceuticals on June 30 for "Treatment of retinitis pigmentosa and retinitis pigmentosa associated with Usher Syndrome with N-acetylcysteine amide" (Texas Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,548, issued on June 30, was assigned to Nacuity Pharmaceuticals Inc. (Fort Worth, Texas). "Treatment of retinitis pigmentosa and retinitis ... और पढ़ें


US Patent Issued to DOMPE FARMACEUTICI on June 30 for "Synergistic admixtures of Gabapentin and Ketoprofen, pharmaceutical compositions and their medical use" (Italian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,549, issued on June 30, was assigned to DOMPE FARMACEUTICI S.P.A. (Milan). "Synergistic admixtures of Gabapentin and Ketoprofen, pharmaceut... और पढ़ें


US Patent Issued to IntraBio on June 30 for "Treatment of late-onset neurodegenerative diseases in heterozygous NPC1 gene mutation carriers" (German Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,550, issued on June 30, was assigned to IntraBio Ltd. (London). "Treatment of late-onset neurodegenerative diseases in heterozygous NPC1 ge... और पढ़ें


US Patent Issued to MARUHA NICHIRO on June 30 for "Renal function maintenance and protection agent, and method for evaluating effect thereof" (Japanese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,551, issued on June 30, was assigned to MARUHA NICHIRO Corp. (Tokyo). "Renal function maintenance and protection agent, and method for eval... और पढ़ें


US Patent Issued to Societe des Produits Nestle on June 30 for "Dietary butyrate" (Swiss, German Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,552, issued on June 30, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland). "Dietary butyrate" was invented by Elizabeth... और पढ़ें


US Patent Issued to Hangzhou Kangyuan Food Technology on June 30 for "Application of medium-chain fatty acid mixed structural lipid in improving diet-induced disorders of glucose and lipid metabolism" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,553, issued on June 30, was assigned to Hangzhou Kangyuan Food Technology Co. LTD (Hangzhou, China). "Application of medium-chain fatty aci... और पढ़ें


US Patent Issued to Ingenus Pharmaceuticals on June 30 for "Oral solid chlorthalidone compositions" (New Jersey Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,554, issued on June 30, was assigned to Ingenus Pharmaceuticals LLC (Orlando, Fla.). "Oral solid chlorthalidone compositions" was invented ... और पढ़ें